FDA establishment 3030304532, Alwar, India. Part of Wizcure Pharmaa Private's FDA records. Every inspection FDA has posted for the site, with its outcome and cited regulations, its recalls since 2016, and the shipments FDA refused at the border.
FY2018 to FY2027 to date; 1 classified OAI
A hatched bar is a year that is not over, so its count covers only part of the year.
| Ended | Product and area | Citations | Classification |
|---|---|---|---|
| Dec 10, 2025 | Drugs ยท Drug Quality Assurance | None posted | Official Action Indicated (OAI) |
| Recalled product | Class | Classified |
|---|---|---|
| Vista Tears Polyethylene Glycol 400 0.4% w/v, Propylene Glycol 0.3% w/v Eye Drops, Dry Eye Relief, LubricantโฆDrug ยท D-0346-2026 ยท 7 products | Class II | Dec 31, 2025 |
| FLUORESCEIN SODIUM (DIAGNOSTIC AID) (DRUGS)Drugs ยท 63XCY12 | Sep 18, 2025 | |
| EMOLLIENT, LUBRICANT, N.E.C.Drugs ยท 64DAL99 | Oct 18, 20242 lines |
An FEI (FDA Establishment Identifier) names one physical site. Inspections, outcomes and citations come from FDA's Data Dashboard; FDA posts citations only for some inspections. Recalls come from FDA's enforcement reports (iRES), one row per recall even when it covers many lots. A contract site can make products for many companies, so the company shown is the one FDA lists as the site's firm. Form 483 observations are read by Arca from the 483s FDA posts in its FOIA reading room, most of them scans: the first sentence of each observation, with redactions as FDA made them. FDA posts 483s for a minority of inspections. FDA Data Dashboard, warning letters and enforcement reports